April 2013 | Oncology & Biotech News

What Really Matters?

May 09, 2013

Discussing prognosis and a treatment plan has been getting particularly complicated with acute myelogenous leukemia with the development and use of molecular markers that confer prognostic and therapeutic information.

Focusing on Clinical and Economic Outcomes-Not Guidelines: Is It Time for a New Direction in Oncology Care?

April 24, 2013

Interview With Andrew Pecora, MD, President, Regional Cancer Care Associates, Chief Innovations Officer and Vice President, Cancer Services, John Theurer Cancer Center at Hackensack University Medical Center, Editor-in-Chief, Oncology & Biotech News

April 2013 Biotech Focus: Tracking the Oncology Pipeline

April 19, 2013

The Biotech Focus series provides updates on advances in the oncology treatment pipeline. In each entry, summaries of ongoing research, breaking news, and FDA decisions relating to a variety of cancers are presented.